AtheroGenomics

AtheroGenomics is a company focused on studying the genetic factors that influence cardiovascular disease, such as heart attacks and strokes. By analyzing patients’ DNA, they aim to identify genetic markers that can predict risks and help develop personalized treatments. Their approach combines genomics (the study of genes) with advanced data analysis to better understand how genetics contribute to artery-clogging conditions. This research can lead to earlier diagnosis, targeted therapies, and improved prevention strategies for cardiovascular health.